Division of Endocrinology, Diabetes and Bone & Mineral Disorders
Acting Division Head: Arti Bhan, M.D.
Our Division offers advanced care for the full range of endocrine conditions, with special expertise in diabetes, thyroid, pituitary and adrenal disease, and osteoporosis. We have a long history of NIH-funded clinical research in advanced diabetes management and a rich history of basic and clinical research in bone and mineral disorders. Our two-year fellowship program offers four positions.
Our endocrinologists are expert in the diagnosis of complex endocrine conditions and perform ultrasound-guided thyroid biopsies. Since the 1950s we have pioneered diabetes management and research and have the largest experience in Michigan with insulin pumps, newer therapies, intensive glucose management, and continuous glucose monitoring devices. Our Bone and Mineral specialists provide bone biopsy and offer expertise in osteoporosis, kidney stones, and other mineral-related disorders.
Our diabetes group participated in the landmark Diabetes Control and Complications Trial (DCCT) as well as the follow-up studies, the Epidemiology of Diabetes Interventions and Complications (EDIC) and the Action to Control Cardiovascular Risk in Diabetes (ACCORD). We continuously offer clinical trial therapies, new medications, and delivery devices to improve diabetes management. The Bone and Mineral Research Unit runs NIH-funded clinical trials on a variety of bone disorders. We were the first bone histomorphometry center in the US, and currently one of only two such centers in the Midwest.
Residents and Endocrinology fellows have the opportunity to see unusual cases via our large population experience, learn how to deliver comprehensive team-based care, and participate in our many research endeavors.